Neo Ivy Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.02M Buy
+95,741
New +$3.74M 1.16% 4
2025
Q4
– Sell
-29,756
Closed -$893K – 342
2025
Q3
$893K Buy
29,756
+13,606
+84% +$384K 0.22% 155
2025
Q2
$462K Buy
+16,150
New +$481K 0.15% 196
2023
Q4
– Sell
-20,132
Closed -$564K – 285
2023
Q3
$564K Buy
+20,132
New +$590K 0.25% 141
2022
Q4
$97K Buy
+3,702
New +$88.6K 0.07% 261
2022
Q3
– Sell
-908
Closed -$27K – 375
2022
Q2
$27K Buy
+908
New +$26.1K 0.07% 287
2022
Q1
– Sell
-259
Closed -$6K – 475
2021
Q4
$6K Buy
+259
New +$6.81K 0.01% 396
2021
Q2
– Sell
-1,574
Closed -$29K – 435
2021
Q1
$29K Buy
1,574
+132
+9% +$2.7K 0.03% 374
2020
Q4
$29K Buy
+1,442
New +$26.4K 0.03% 344

Other funds holding ALKS

Neo Ivy Capital Management's ALKS Position: Q2 2026 in Review

Neo Ivy Capital Management opened a new position in Alkermes (ALKS) in Q2 2026: 95,741 shares worth $5.02M. The stake represents 1.16% of the portfolio and ranks #4 among its holdings. This is a return to the name: Neo Ivy Capital Management previously reported a position in ALKS as recently as Q3 2025.

Neo Ivy Capital Management first reported a position in ALKS in Q4 2020 and has held it in 9 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Neo Ivy Capital Management held 95,741 shares of Alkermes worth $5.02M as of Q2 2026.
  • Alkermes was a new Neo Ivy Capital Management position in Q2 2026.
  • Alkermes made up 1.16% of Neo Ivy Capital Management's portfolio in Q2 2026, its #4 holding.
  • Neo Ivy Capital Management first reported a position in Alkermes in Q4 2020 and has held it in 9 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Neo Ivy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.